Neoadjuvant treatment Cure Palliation Monoclonal antibody Adenocarcinoma Tyrosine kinase inhibitors (TKIs) Chemotherapy TNM staging system Partial Remission performance status Sarcoma CTACAE Clinical stage Complementary therapy Maintenance chemotherapy ECOG performance status leukemia Maintenance chemotherapy Minimal residual disease (MRD) Tumor Surgical margin Active surveillance Definitive treatment Pathological stage Recurrence Complete remission Carcinoma Refractory Adjuvant treatment Cellular therapy Grade 3, 4, or 5 Checkpoint inhibitor Relapse Antibody Drug Conjugate (ADCs) Neoadjuvant treatment Cure Palliation Monoclonal antibody Adenocarcinoma Tyrosine kinase inhibitors (TKIs) Chemotherapy TNM staging system Partial Remission performance status Sarcoma CTACAE Clinical stage Complementary therapy Maintenance chemotherapy ECOG performance status leukemia Maintenance chemotherapy Minimal residual disease (MRD) Tumor Surgical margin Active surveillance Definitive treatment Pathological stage Recurrence Complete remission Carcinoma Refractory Adjuvant treatment Cellular therapy Grade 3, 4, or 5 Checkpoint inhibitor Relapse Antibody Drug Conjugate (ADCs)
(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.
Neoadjuvant treatment
Cure
Palliation
Monoclonal antibody
Adenocarcinoma
Tyrosine kinase inhibitors (TKIs)
Chemotherapy
TNM staging system
Partial Remission
performance status
Sarcoma
CTACAE
Clinical stage
Complementary therapy
Maintenance chemotherapy
ECOG performance status
leukemia
Maintenance chemotherapy
Minimal residual disease (MRD)
Tumor
Surgical margin
Active surveillance
Definitive treatment
Pathological stage
Recurrence
Complete remission
Carcinoma
Refractory
Adjuvant treatment
Cellular therapy
Grade 3, 4, or 5
Checkpoint inhibitor
Relapse
Antibody Drug Conjugate (ADCs)